LONDON, Dec 29 (Reuters) - Ask executives in the healthcare industry about the future market for weight-loss drugs and the analogies are telling: monthly GLP-1 medicine subscriptions like a streaming ...
Though recent data shows a meaningful decrease in the U.S. adult obesity rate (37 percent in 2025 compared with a record high of 39.9 percent in 2022), the need for obesity treatments is still ...
Novo Nordisk has launched the first once-daily GLP-1 weight-loss pill, an oral version of Wegovy approved by the FDA last month. Clinical trials showed the Wegovy pill delivered average weight loss of ...
LONDON, Dec 29 (Reuters) - Ask executives in the healthcare industry about the future market for weight-loss drugs and the analogies are telling: monthly GLP-1 medicine subscriptions like a streaming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results